Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Mol Cell. 2010 Jan 15;37(1):57-66. doi: 10.1016/j.molcel.2009.12.012.
HBO1, an H4-specific histone acetylase, is a coactivator of the DNA replication licensing factor Cdt1. HBO1 acetylase activity is required for licensing, because a histone acetylase (HAT)-defective mutant of HBO1 bound at origins is unable to load the MCM complex. H4 acetylation at origins is cell-cycle regulated, with maximal activity at the G1/S transition, and coexpression of HBO1 and Jade-1 increases histone acetylation and MCM complex loading. Overexpression of the Set8 histone H4 tail-binding domain specifically inhibits MCM loading, suggesting that histones are a physiologically relevant target for licensing. Lastly, Geminin inhibits HBO1 acetylase activity in the context of a Cdt1-HBO1 complex, and it associates with origins and inhibits H4 acetylation and licensing in vivo. Thus, H4 acetylation at origins by HBO1 is critical for replication licensing by Cdt1, and negative regulation of licensing by Geminin is likely to involve inhibition of HBO1 histone acetylase activity.
HBO1 是一种特异性组蛋白 H4 乙酰转移酶,是 DNA 复制起始因子 Cdt1 的共激活因子。HBO1 乙酰转移酶活性对于起始复制是必需的,因为在原点结合的 HBO1 组蛋白乙酰转移酶缺陷突变体无法加载 MCM 复合物。H4 在原点的乙酰化呈细胞周期调控,在 G1/S 转换时活性最大,并且 HBO1 和 Jade-1 的共表达增加了组蛋白乙酰化和 MCM 复合物的加载。Set8 组蛋白 H4 尾部结合结构域的过表达特异性抑制 MCM 加载,表明组蛋白是许可的生理相关靶标。最后,Geminin 在 Cdt1-HBO1 复合物的背景下抑制 HBO1 乙酰转移酶活性,并且在体内与原点结合并抑制 H4 乙酰化和许可。因此,HBO1 在原点对 H4 的乙酰化对于 Cdt1 的复制许可至关重要,而 Geminin 对许可的负调控可能涉及抑制 HBO1 组蛋白乙酰转移酶活性。